Compare Abbott Laboratories (ABT) vs Ecopetrol SA (EC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Ecopetrol SA — how do they compare? Abbott Laboratories trades at $95.33 (market cap $166.94B), while Ecopetrol SA trades at $15.06 (market cap $28.19B). The key difference: Abbott Laboratories is far larger — about 5.9× Ecopetrol SA's market cap, and Ecopetrol SA pays the higher dividend (4.42%). Which is the better fit depends on your goals.
| ABT | EC | |
|---|---|---|
Market Cap | $166.94B | $28.19B |
Sector | Health | Energy |
52-Week High | $136.62 | $16.58 |
52-Week Low | $82.57 | $8.29 |
Enterprise Value | $193.69B | $55.97B |
Dividend Yield | 2.63% | 4.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Ecopetrol (EC) trades at $14.69, slightly below the consensus price target of $14.63, with a bearish technical signal and mixed earnings performance. Recent quarters show misses against EPS expectations, while revenue has declined from $159.6T in 2022 to $119.7T in 2025. The company maintains a dividend payout, with a recent H1-26 dividend of $0.66, and holds a BB- credit rating with a stable outlook as affirmed by S&P Global Ratings on June 17, 2026.
The outlook remains cautious due to declining revenue and profitability trends, offset by attractive valuation multiples like a P/E of 10.31. Key risks include operational execution in the energy sector and macroeconomic pressures on oil demand. Analyst sentiment is mixed with a Hold-dominated consensus, suggesting limited near-term upside potential amid ongoing fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →
